Clinical trial
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial
NCT04448873 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial
- Lead sponsor
- Children's Hospital of Fudan University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2020
- Completion date
- July 1, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kaposiform hemangioendothelioma, kasabach-merritt syndrome